Association between Dupilumab and Ocular Surface Diseases in Children. [PDF]
Ophthalmol SciAyoubi M +6 more
europepmc +1 more source
Case Series: Combination of dupilumab and omalizumab as a way to reduce dupilumab-associated adverse events in severe atopic dermatitis. [PDF]
Front AllergyFomina DS +7 more
europepmc +1 more source
Novel Therapeutic Strategies for Atopic Dermatitis: Biomarker Modulation and Clinical Implications. A Systematic Review. [PDF]
Clin Rev Allergy ImmunolMoreiras-Arias N +7 more
europepmc +1 more source
Dupilumab treatment is not associated with changes in lymphoma risk in atopic dermatitis and other type 2 inflammatory diseases: data from a large-scale retrospective cohort study. [PDF]
Front Med (Lausanne)Kridin K +8 more
europepmc +1 more source
Dupilumab in Elderly Patients with Atopic Dermatitis-A Systematic Review and Meta-Analysis. [PDF]
BiomedicinesHałubiec P +4 more
europepmc +1 more source
The Therapeutic Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): A Review of the Current Evidence. [PDF]
Ther Clin Risk ManagChen W +5 more
europepmc +1 more source
Comment on published article "A Real-World Study of Tofacitinib in Indian Patients with Refractory Moderate-to-Severe Atopic Dermatitis, its Economic Considerations and Immunological Rationale". [PDF]
Indian Dermatol Online JGupta A, Neema S.
europepmc +1 more source
Unexpected systemic sclerosis in a patient with atopic dermatitis receiving dupilumab: a novel case report. [PDF]
Skin Health DisGazal E +3 more
europepmc +1 more source
Dupilumab attenuates the expression of TSLP and IL-8 induced by dsRNA and IL-4/IL-13 co-stimulation in human small airway epithelial cells. [PDF]
PLoS OneSri Listyoko A +8 more
europepmc +1 more source